These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12936981)

  • 1. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.
    Schneiders T; Amyes SG; Levy SB
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2831-7. PubMed ID: 12936981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
    Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.
    Wang H; Dzink-Fox JL; Chen M; Levy SB
    Antimicrob Agents Chemother; 2001 May; 45(5):1515-21. PubMed ID: 11302820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City.
    Bratu S; Landman D; George A; Salvani J; Quale J
    J Antimicrob Chemother; 2009 Aug; 64(2):278-83. PubMed ID: 19457933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline Susceptibility and Molecular Resistance Mechanisms Among Clinical Klebsiella pneumoniae Strains Isolated During Non-Tigecycline Treatment.
    Li R; Han Y; Zhou Y; Du Z; Wu H; Wang J; Chen Y
    Microb Drug Resist; 2017 Mar; 23(2):139-146. PubMed ID: 27219271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of AcrAB-TolC Efflux Pump in Mediating Fluoroquinolone Resistance in Naturally Occurring Salmonella Isolates from China.
    Shen J; Yang B; Gu Q; Zhang G; Yang J; Xue F; Shao J; Yi X; Jiang Y
    Foodborne Pathog Dis; 2017 Dec; 14(12):728-734. PubMed ID: 28926285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital.
    Zhong X; Xu H; Chen D; Zhou H; Hu X; Cheng G
    PLoS One; 2014; 9(12):e115185. PubMed ID: 25503276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
    Roy S; Datta S; Viswanathan R; Singh AK; Basu S
    J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of
    Chiu SK; Huang LY; Chen H; Tsai YK; Liou CH; Lin JC; Siu LK; Chang FY; Yeh KM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia.
    Saiful Anuar AS; Mohd Yusof MY; Tay ST
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1744-7. PubMed ID: 23852897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RamA upregulates multidrug resistance efflux pumps AcrAB and OqxAB in Klebsiella pneumoniae.
    Xu Q; Sheng Z; Hao M; Jiang J; Ye M; Chen Y; Xu X; Guo Q; Wang M
    Int J Antimicrob Agents; 2021 Feb; 57(2):106251. PubMed ID: 33259915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone and multidrug resistance phenotypes associated with the overexpression of AcrAB and an orthologue of MarA in Yersinia enterocolitica.
    Fàbrega A; Roca I; Vila J
    Int J Med Microbiol; 2010 Nov; 300(7):457-63. PubMed ID: 20510648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Tigecycline Resistance in Carbapenemase-Producing
    Yoon EJ; Oh Y; Jeong SH
    Ann Lab Med; 2020 Jan; 40(1):15-20. PubMed ID: 31432634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae.
    Bialek-Davenet S; Marcon E; Leflon-Guibout V; Lavigne JP; Bert F; Moreau R; Nicolas-Chanoine MH
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2795-802. PubMed ID: 21464248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
    He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
    PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae.
    Chen FJ; Lauderdale TL; Ho M; Lo HJ
    Microb Drug Resist; 2003; 9(3):265-71. PubMed ID: 12959405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    FEMS Microbiol Lett; 2004 Sep; 238(1):267-72. PubMed ID: 15336432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region.
    Taneja N; Mishra A; Kumar A; Verma G; Sharma M
    Indian J Med Res; 2015 Jan; 141(1):81-9. PubMed ID: 25857499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.